Background: Inadequate or inappropriate medication treatment is a major risk factor for medication-related diseases. Determining the prevalence of potentially inappropriate prescription and drug-disease interactions in hospitalized patients is an important step to resolving these problems. Methods: A sample of 500 geriatric patients hospitalized between June 2021 and December 2021 were included in the study. Medication prescribed before (usual medication), during, and at hospital discharge was considered. Results: The prevalence of prescription of at least one inappropriate drug on hospital admission, during hospitalization, and at discharge was 9.8 %, 3.6%, and 2.4 % respectively. The drugs most frequently implicated in hospital admission were diazepam, digoxin, iron products, chlorpheniramine, and amitriptyline. The significant adverse drug-disease interaction on hospital admission, during hospitalization, and at discharge was 13.0%, 3.2%, and 3.4%, respectively. The variables number of drugs at admission and the number of diseases and the pain item of the COOP/WONCA score were statistically significant. Conclusions:The study reveals the existence of potentially inappropriate drug prescriptions or potentially adverse drugdisease interaction in hospitalized patients in our environment. Polypharmacy, polypathology, and the presence of chronic pain were associated with potentially inappropriate prescriptions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.